A defensible comparison of automated microbiology systems starts with the laboratory's own specimen mix, staffing model, and verification obligations. CLSI M67 describes verification for specimen processing, plate transport and incubation, plate imaging, and digital plate reading, but it does not rank vendors or prescribe a single configuration [1]. Procurement teams therefore need to separate documented performance from marketing claims. Published audits report that full laboratory automation can reduce full-time equivalent requirements across facilities of different sizes, while a focused study reports large reductions in urine culture setup time [2][6]. The useful comparison is not which platform is best in general, but which documented workflow and evidence package matches a specific laboratory's operating constraints.
Verification Scope and Regulatory Evidence
CLSI M67 frames automation as a set of modules rather than one monolithic purchase. The guideline covers specimen processing, plate transport and incubation, plate imaging, and software for digital plate reading and image analysis, along with staged or all-at-once implementation [1]. A procurement comparison should ask whether the vendor can support verification for each module the laboratory intends to adopt. The document also addresses postverification quality assurance, including downtime management, verification after changes, proficiency testing, and personnel management [1]. These are operational commitments that extend well beyond installation.
For image assessment systems marketed in the United States, 21 CFR 866.2190 imposes Class II special controls. Premarket submissions must describe result algorithms and expert rules, document analytical and clinical studies against an acceptable reference method, and address software integration when the device is part of a total laboratory automation system [7]. Labeling must explain result interpretation and the need for review by a qualified microbiologist [7]. Procurement teams can use these requirements to compare the depth of evidence a vendor can supply, but the regulation does not establish clinical superiority for any product.
Workflow Timing and Staffing Effects
A four-laboratory study of Copan's full laboratory automation system found productivity gains across facilities with different culture volumes. At Hamilton Regional Medicine Laboratory Program, peak specimen volume rose from approximately 957 to 1,565 specimens per day, while productivity increased from 191 to 224 specimens processed per full-time equivalent and from 53 to 92 cultures worked up per FTE [2]. The authors reported a combined productivity increase of 55% at that site [2]. These figures describe one vendor's system in specific laboratories and should not be treated as universal benchmarks.
A hospital study comparing total laboratory automation with manual urine culture inoculation reported setup time reductions from 10 minutes 10 seconds to 2 minutes 5 seconds for experts and from 13 minutes 37 seconds to 2 minutes 20 seconds for non-experts [6]. Total staff time decreased from 11 minutes 6 seconds to 2 minutes 30 seconds for experts and from 14 minutes 37 seconds to 3 minutes 15 seconds for non-experts [6]. The study also found that manual processing showed greater operator-dependent variability, which automation substantially reduced [6]. These results are specific to urine culture inoculation during staffed daytime hours and do not cover overnight processing.
Documentation to Request Before a Site Visit
Request the vendor's verification plan mapped to CLSI M67 modules, including downtime procedures and post-change verification [1]. For US image assessment systems, ask for the 510(k) summary or equivalent documentation showing analytical studies, clinical studies against a reference method, and software integration details [7]. Request workflow data with denominators, peak-day volumes, and FTE definitions rather than percentage-only claims [2]. Ask whether the vendor's identification and AST systems support the incubation durations the automation platform enables [3]. Confirm regulatory status by country, since product availability and approval vary by region [4].
Culture Read Timing and Identification Accuracy
A study using Copan WaspLab automation evaluated whether earlier culture reads affect identification and antimicrobial susceptibility testing. Among 374 patient specimens, over 50% of non-urine specimens were ready for workup at 16 hours, 92% by 24 hours, and 100% by 36 hours, while 90% of urine cultures were ready by 16 hours [3]. Using frozen isolates, MALDI-TOF identification accuracy remained high at 10 and 16 hours, with gram-negative bacteria at 98.8% and 97.6%, gram-positive bacteria at 97.6% and 98.4%, and yeasts at 91.6% and 100% [3].
The same study reported essential agreement above 90% for most drugs on Vitek 2 AST cards, but elevated error rates for specific drugs such as cefazolin, piperacillin/tazobactam, nitrofurantoin, and linezolid [3]. The authors attributed these errors partly to limited susceptible isolate counts and breakpoint-related challenges [3]. Procurement teams should note that manufacturers of identification and AST systems do not currently accommodate reduced incubation durations with automation platforms [3]. This creates a practical constraint when comparing systems that promise earlier reads.
Comparing Identification Platforms Within an Automated Workflow
A side-by-side study of the VITEK MS PRIME and MALDI Biotyper sirius processed 618 bacterial isolates from a tertiary hospital laboratory [5]. The identification rate without retesting was 97.9% for VITEK MS PRIME and 98.9% for Biotyper sirius, with 100% agreement at genus level and 96.2% at species level [5]. The Biotyper workflow had shorter hands-on time by 3 to 6 minutes during target preparation, while time to result was three to five times shorter for the Biotyper sirius [5].
The VITEK MS PRIME had significantly shorter hands-on time during measurement, approximately 1.5 minutes per target [5]. The authors concluded that the Biotyper sirius suits laboratories with high sample throughput and larger batch processing, while the VITEK MS PRIME suits laboratories with fewer identifications but more targets and parallel workstation workflows [5]. This comparison is limited to MALDI-TOF identification and does not address inoculation, incubation, or imaging modules. Procurement teams should treat identification platform choice as a separate decision point from front-end automation.
A Suggested Evaluation Scenario
A procurement team could structure a comparison around a hypothetical 600-bed hospital processing 800 bacteriology specimens per peak day, with urine cultures representing 40% of volume and staffing limited to two daytime shifts. The team would first map which CLSI M67 modules are required: specimen processing, plate transport and incubation, imaging, and digital plate reading [1]. For each vendor, the team would request documentation showing verification support for those modules and evidence of software integration under 21 CFR 866.2190 if the imaging component is marketed in the United States [7].
The team would then compare documented staffing effects using the four-laboratory Copan study and the urine culture timing study as reference points, while acknowledging that neither study covers the hospital's exact specimen mix [2][6]. For identification, the team would evaluate the VITEK MS PRIME and Biotyper sirius data against the hospital's batch size and parallel workstation design [5]. This scenario is a suggested analytical structure, not a tested procurement outcome. No source in this review establishes a winner for a 600-bed hospital.
Sources & references
- https://cdn.bfldr.com/YLD4EVFU/at/98qg6h3vxspfk44ffr7f78vx/M67Ed1E_sample.pdf · cdn.bfldr.com
- Benefits Derived from Full Laboratory Automation in Microbiology: a Tale of Four Laboratories · pmc.ncbi.nlm.nih.gov
- Optimization of culture read times using full microbiology laboratory automation | Journal of Clinical Microbiology · journals.asm.org
- Streamline Your Laboratory Workflow - Copan Diagnostics · www.copanusa.com
- A side-by-side comparison of the new VITEK MS PRIME and the MALDI Biotyper sirius in the clinical microbiology laboratory - PMC · pmc.ncbi.nlm.nih.gov
- Total Laboratory Automation Versus Manual Processing in Urine Culture Inoculation and Interpretation: A Hospital Experience · pmc.ncbi.nlm.nih.gov
- 21 CFR § 866.2190 Automated image assessment system for microbial colonies on solid culture media. · www.ecfr.gov